Tag: Virtual screening

In a 2024 study, researchers demonstrated that high-quality data representation could enable a conventional machine learning algorithm to achieve 99% accuracy in a virtual screening task, far surpassing more complex deep learning methods. This illustrates that a key requirement for *in silico* screening is not just powerful algorithms, but meticulously curated, high-fidelity data.

According to a recent industry analysis, the market for in silico technologies was valued at approximately $8.3 billion in 2022, demonstrating its significant impact on pharmaceutical research. This article explores what is the meaning of in silico drug discovery, explaining how it uses computational techniques to accelerate and refine the development of new medicines.